AVEO Oncology
AVEO
#7488
Rank
C$0.74 B
Marketcap
C$21.38
Share price
0.00%
Change (1 day)
175.59%
Change (1 year)

AVEO Oncology (AVEO) - Net assets

Net assets on the balance sheet as of September 2022 : C$41.11 Million

According to AVEO Oncology 's latest financial reports the company has C$41.11 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AVEO Oncology - Net assets on balance sheet (from 2008 to 2022)

Net assets by year

Year Net assets Change
2021-12-31$C$58.45 M29.9%
2020-12-31$C$45 M132.09%
2019-12-31$C$19.38 M-152.28%
2018-12-31$-C$37.09 Million-27.63%
2017-12-31$-C$51.25 Million1883.16%
2016-12-31$-C$2.59 Million-110.81%
2015-12-31$C$23.89 M-0.07%
2014-12-31$C$23.91 M-67.88%
2013-12-31$C$74.44 M-37.05%
2012-12-31$C$0.11 B-47.99%
2011-12-31$C$0.22 B216.95%
2010-12-31$C$71.74 M-662.22%
2009-12-31$-C$12.77 Million-91.84%
2008-12-31$-C$0.16 Billion59.3%
2007-12-31$-C$98.23 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Eli Lilly
LLY
C$48.29 B 117,351.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$16.66 B 40,420.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$26.86 B 65,242.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$45.20 B 109,837.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$31.81 B 77,275.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$0.31 B 668.42%๐Ÿ‡บ๐Ÿ‡ธ USA